Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 9Lymphoma, Follicular 4Lymphoma, Large B-Cell, Diffuse 3Recurrence 2Graft vs Host Disease 2Ulcer 1Stomatitis 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Oral Ulcer 1Metastatic Castration-Resistant Prostate Cancer 1Melanoma 1Lymphoma, B-Cell 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Intestinal Obstruction 1Colitis, Ulcerative 1Colitis 1Carcinoma, Renal Cell 1Carcinoma 1Breast Neoplasms 1

Interventions

vedolizumab 1Photopheresis 1Mycophenolic Acid 1Methylprednisolone 1Methoxsalen 1Infliximab 1Azathioprine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Colitis × Methylprednisolone × Clear all
NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Prometheus Laboratories

Phase 2 Completed
190 enrolled
Lymphoid

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡